日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of a series of pyrrolo-pyrimidine-based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication

鉴定出一系列基于吡咯并嘧啶的SARS-CoV-2 Mac1抑制剂,这些抑制剂能够抑制冠状病毒的复制

Pfannenstiel, Jessica J; Duong, Men Thi Hoai; Cluff, Daniel; Sherrill, Lavinia M; Colquhoun, Iain; Cadoux, Gabrielle; Thorne, Devyn; Pääkkönen, Johan; Schemmel, Nathaniel F; O'Connor, Joseph; Saenjamsai, Pradtahna; Feng, Mei; Parthasarathy, Srivatsan; Hageman, Michael J; Johnson, David K; Roy, Anuradha; Lehtiö, Lari; Ferraris, Dana V; Fehr, Anthony R

Developing Subcutaneous Formulations for Irisin as a Potential Therapeutic

开发鸢尾素皮下制剂作为潜在治疗药物

Hu, Gang; Luan, Xi; Hageman, Michael J; Lou, Hao

Investigating the impact of charge and hydrophilicity on peptide-mucin interactions using a simple mucin model

利用简单的粘蛋白模型研究电荷和亲水性对肽-粘蛋白相互作用的影响

Elballa, Waleed M; Gregory, Aiden; Siahaan, Teruna J; Hageman, Michael J

Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication.

鉴定出一系列基于吡咯并嘧啶的SARS-CoV-2 Mac1抑制剂,这些抑制剂能够抑制冠状病毒的复制

Pfannenstiel Jessica J, Duong Men Thi Hoai, Cluff Daniel, Sherrill Lavania M, Colquhoun Iain, Cadoux Gabrielle, Thorne Devyn, Pääkkönen Johan, Schemmel Nathaniel F, O'Connor Joseph, Saenjamsai Pradtahna, Feng Mei, Hageman Michael J, Johnson David K, Roy Anuradha, Lehtiö Lari, Ferraris Dana V, Fehr Anthony R

Development of Drug Release Model for Suspensions in ESCAR (Emulator of SubCutaneous Absorption and Release)

在ESCAR(皮下吸收和释放模拟器)中开发混悬液药物释放模型

Lou, Hao; Hageman, Michael J

Development of an In Vitro System To Emulate an In Vivo Subcutaneous Environment: Small Molecule Drug Assessment

开发模拟体内皮下环境的体外系统:小分子药物评估

Lou, Hao; Hageman, Michael J